Home » Newsletters » BioWorld

BioWorld

Jan. 20, 2005

View Archived Issues

It's Official: Inex's Marqibo Gets Not-Approvable Letter From FDA

As expected, the FDA turned down Inex Pharmaceuticals Corp.'s Marqibo (vincristine sulfate liposomes injection). (BioWorld Today) Read More

Synta Files For $115M IPO; Proceeds To Push Pipeline

AVI Sky High On Patents, Potential For State Funds

Neoprobe Forms Subsidiary As Home For ACT Platform

Other News To Note

U.S. Patent Disclosures